Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Containment measures for emerging and re-emerging vector-borne and other infectious diseases of poverty in urban settings: a scoping review.

Campeau L, Degroote S, Ridde V, Carabali M, Zinszer K.

Infect Dis Poverty. 2018 Sep 3;7(1):95. doi: 10.1186/s40249-018-0478-4. Review.

2.

Beta-3 adrenoceptor signaling pathways in urothelial and smooth muscle cells in the presence of succinate.

Mossa AH, Velasquez Flores M, Nguyen H, Cammisotto P, Campeau L.

J Pharmacol Exp Ther. 2018 Aug 13. pii: jpet.118.249979. doi: 10.1124/jpet.118.249979. [Epub ahead of print]

3.

Teaching and evaluation of basic urodynamic skills in urology residency programs: Randomized controlled study.

Shamout S, Andonian S, Kabbara H, Corcos J, Campeau L.

Neurourol Urodyn. 2018 Jun 8. doi: 10.1002/nau.23728. [Epub ahead of print]

PMID:
29882281
4.

Short-term evaluation of the adjustable bulbourethral male sling for post-prostatectomy urinary incontinence.

Shamout S, Huang YQ, Kabbara H, Corcos J, Campeau L.

Low Urin Tract Symptoms. 2018 Jun 4. doi: 10.1111/luts.12227. [Epub ahead of print]

PMID:
29869450
5.

How long do we have to treat overactive bladder syndrome (OAB)? A questionnaire survey of Canadian urologists and gynecologists.

Przydacz M, Campeau L, Walter JE, Corcos J.

Can Urol Assoc J. 2018 May 14. doi: 10.5489/cuaj.5032. [Epub ahead of print]

PMID:
29787370
6.

Succinate decreases bladder function in a rat model associated with metabolic syndrome.

Velasquez Flores M, Mossa AH, Cammisotto P, Campeau L.

Neurourol Urodyn. 2018 Jun;37(5):1549-1558. doi: 10.1002/nau.23488. Epub 2018 Apr 18.

PMID:
29667730
7.

A cost-utility analysis of artificial urinary sphincter versus AdVance male sling in post prostatectomy stress urinary incontinence: A publicly funded health care perspective.

Shamout S, Nazha S, Dragomir A, Campeau L.

Neurourol Urodyn. 2018 Sep;37(7):2195-2203. doi: 10.1002/nau.23559. Epub 2018 Apr 10.

PMID:
29635704
8.

Bladder overdistension with polyuria in a hypertensive rat model.

Velasquez Flores M, Mossa AH, Cammisotto P, Campeau L.

Neurourol Urodyn. 2018 Mar 31. doi: 10.1002/nau.23550. [Epub ahead of print]

PMID:
29603801
9.

Impact of sex work on risk behaviours and their association with HIV positivity among people who inject drugs in Eastern Central Canada: cross-sectional results from an open cohort study.

Campeau L, Blouin K, Leclerc P, Alary M, Morissette C, Blanchette C, Serhir B, Roy E; SurvUDI Working Group.

BMJ Open. 2018 Jan 31;8(1):e019388. doi: 10.1136/bmjopen-2017-019388.

10.

Montreal electronic artificial urinary sphincters: Our futuristic alternatives to the AMS800™.

Biardeau X, Hached S, Loutochin O, Campeau L, Sawan M, Corcos J.

Can Urol Assoc J. 2017 Oct;11(10):E396-E404. doi: 10.5489/cuaj.4493.

11.

Lumbar to sacral root rerouting to restore bladder function in a feline spinal cord injury model: Urodynamic and retrograde nerve tracing results from a pilot study.

Lam Van Ba O, Barbe MF, Caremel R, Aharony S, Loutochin O, Jacques L, Wood MW, Tiwari E, Tuite GF, Campeau L, Corcos J, Ruggieri MR Sr.

Neurourol Urodyn. 2018 Jan;37(1):153-162. doi: 10.1002/nau.23394. Epub 2018 Jan 4.

PMID:
29314212
12.

Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer.

Hicks BM, Klil-Drori AJ, Yin H, Campeau L, Azoulay L.

Epidemiology. 2017 Sep;28(5):712-718. doi: 10.1097/EDE.0000000000000678.

PMID:
28768300
13.

Stress urinary incontinence in women: Current and emerging therapeutic options.

Shamout S, Campeau L.

Can Urol Assoc J. 2017 Jun;11(6Suppl2):S155-S158. doi: 10.5489/cuaj.4613. Review.

14.

Succinate, increased in metabolic syndrome, activates GPR91 receptor signaling in urothelial cells.

Mossa AH, Velasquez Flores M, Cammisotto PG, Campeau L.

Cell Signal. 2017 Sep;37:31-39. doi: 10.1016/j.cellsig.2017.05.014. Epub 2017 May 26.

PMID:
28554536
15.

A rational pre-catalyst design for bis-phosphine mono-oxide palladium catalyzed reactions.

Ji Y, Li H, Hyde AM, Chen Q, Belyk KM, Lexa KW, Yin J, Sherer EC, Williamson RT, Brunskill A, Ren S, Campeau LC, Davies IW, Ruck RT.

Chem Sci. 2017 Apr 1;8(4):2841-2851. doi: 10.1039/c6sc05472b. Epub 2017 Jan 19.

16.

Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice.

Biardeau X, Lam O, Ba V, Campeau L, Corcos J.

Can Urol Assoc J. 2017 Mar-Apr;11(3-4):104-110. doi: 10.5489/cuaj.4127.

17.

Appendix: Executive summary of CUA guideline on adult overactive bladder.

Corcos J, Przydacz M, Campeau L, Gray G, Hickling D, Honeine C, Radomski SB, Stothers L, Wagg A.

Can Urol Assoc J. 2017 May;11(5):E248-E249. Epub 2017 May 9. No abstract available. Erratum in: Can Urol Assoc J. 2017 Jul;11(7):E323.

18.

CUA guideline on adult overactive bladder.

Corcos J, Przydacz M, Campeau L, Gray G, Hickling D, Honeine C, Radomski SB, Stothers L, Wagg A, Lond F.

Can Urol Assoc J. 2017 May;11(5):E142-E173. doi: 10.5489/cuaj.4586. Epub 2017 May 9. No abstract available. Erratum in: Can Urol Assoc J. 2017 May;11(5):E250. Can Urol Assoc J. 2017 Jul;11(7):E323.

19.

A multifunctional catalyst that stereoselectively assembles prodrugs.

DiRocco DA, Ji Y, Sherer EC, Klapars A, Reibarkh M, Dropinski J, Mathew R, Maligres P, Hyde AM, Limanto J, Brunskill A, Ruck RT, Campeau LC, Davies IW.

Science. 2017 Apr 28;356(6336):426-430. doi: 10.1126/science.aam7936.

PMID:
28450641
20.

Best practice policy statement on urodynamic antibiotic prophylaxis in the non-index patient.

Cameron AP, Campeau L, Brucker BM, Clemens JQ, Bales GT, Albo ME, Kennelly MJ.

Neurourol Urodyn. 2017 Apr;36(4):915-926. doi: 10.1002/nau.23253. Epub 2017 Mar 27. Review.

PMID:
28345769
21.

Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIV.

Schreier JD, Embrey MW, Raheem IT, Barbe G, Campeau LC, Dubost D, McCabe Dunn J, Grobler J, Hartingh TJ, Hazuda DJ, Klein D, Miller MD, Moore KP, Nguyen N, Pajkovic N, Powell DA, Rada V, Sanders JM, Sisko J, Steele TG, Wai J, Walji A, Xu M, Coleman PJ.

Bioorg Med Chem Lett. 2017 May 1;27(9):2038-2046. doi: 10.1016/j.bmcl.2017.02.039. Epub 2017 Feb 20.

PMID:
28285916
22.

Design and Synthesis of Novel, Selective GPR40 AgoPAMs.

Plummer CW, Clements MJ, Chen H, Rajagopalan M, Josien H, Hagmann WK, Miller M, Trujillo ME, Kirkland M, Kosinski D, Mane J, Pachanski M, Cheewatrakoolpong B, Nolting AF, Orr R, Christensen M, Campeau LC, Wright MJ, Bugianesi R, Souza S, Zhang X, Di Salvo J, Weinglass AB, Tschirret-Guth R, Nargund R, Howard AD, Colletti SL.

ACS Med Chem Lett. 2017 Jan 23;8(2):221-226. doi: 10.1021/acsmedchemlett.6b00443. eCollection 2017 Feb 9.

23.

Discovery of phenyl acetamides as potent and selective GPR119 agonists.

Zhu C, Wang L, Zhu Y, Guo ZZ, Liu P, Hu Z, Szewczyk JW, Kang L, Chicchi G, Ehrhardt A, Woods A, Seo T, Woods M, van Heek M, Dingley KH, Pang J, Salituro GM, Powell J, Terebetski JL, Hornak V, Campeau LC, Orr RK, Ujjainwalla F, Miller M, Stamford A, Wood HB, Kowalski T, Nargund RP, Edmondson SD.

Bioorg Med Chem Lett. 2017 Mar 1;27(5):1124-1128. doi: 10.1016/j.bmcl.2017.01.091. Epub 2017 Feb 1.

PMID:
28185720
24.

Outcome comparison of different approaches to self-intermittent catheterization in neurogenic patients: a systematic review.

Shamout S, Biardeau X, Corcos J, Campeau L.

Spinal Cord. 2017 Jul;55(7):629-643. doi: 10.1038/sc.2016.192. Epub 2017 Jan 24. Review.

PMID:
28117329
25.

Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model.

Biardeau X, Przydacz M, Aharony S, Loutochin G, Campeau L, Kyheng M, Corcos J.

PLoS One. 2017 Jan 6;12(1):e0169694. doi: 10.1371/journal.pone.0169694. eCollection 2017.

26.

Radiation Exposure During Videourodynamics: Establishing Risk Factors.

Brucker BM, Campeau L, Fong E, Kalra S, Rosenblum N, Nitti VW.

Low Urin Tract Symptoms. 2018 May;10(2):181-185. doi: 10.1111/luts.12161. Epub 2016 Dec 19.

PMID:
27990783
27.

Acridinium-Based Photocatalysts: A Sustainable Option in Photoredox Catalysis.

Joshi-Pangu A, Lévesque F, Roth HG, Oliver SF, Campeau LC, Nicewicz D, DiRocco DA.

J Org Chem. 2016 Aug 19;81(16):7244-9. doi: 10.1021/acs.joc.6b01240. Epub 2016 Jul 25.

PMID:
27454776
28.

The Discovery of Quinoxaline-Based Metathesis Catalysts from Synthesis of Grazoprevir (MK-5172).

Williams MJ, Kong J, Chung CK, Brunskill A, Campeau LC, McLaughlin M.

Org Lett. 2016 May 6;18(9):1952-5. doi: 10.1021/acs.orglett.6b00070. Epub 2016 Apr 28.

PMID:
27123552
29.

Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods.

Kutchukian PS, Dropinski JF, Dykstra KD, Li B, DiRocco DA, Streckfuss EC, Campeau LC, Cernak T, Vachal P, Davies IW, Krska SW, Dreher SD.

Chem Sci. 2016 Apr 21;7(4):2604-2613. doi: 10.1039/c5sc04751j. Epub 2016 Jan 26.

30.

Artificial Urinary Sphincter: Report of the 2015 Consensus Conference.

Biardeau X, Aharony S; AUS Consensus Group, Campeau L, Corcos J.

Neurourol Urodyn. 2016 Apr;35 Suppl 2:S8-24. doi: 10.1002/nau.22989.

PMID:
27064055
31.

Artificial Urinary Sphincter: Executive Summary of the 2015 Consensus Conference.

Biardeau X, Aharony S; AUS Consensus Group, Campeau L, Corcos J.

Neurourol Urodyn. 2016 Apr;35 Suppl 2:S5-7. doi: 10.1002/nau.23001. No abstract available.

PMID:
27064054
32.

We should not use oxybutynin chloride in OAB.

Biardeau X, Campeau L, Corcos J.

Neurourol Urodyn. 2017 Mar;36(3):822-823. doi: 10.1002/nau.22991. Epub 2016 Mar 21. No abstract available.

PMID:
26999690
33.

Overview of the 2015 ICS Consensus Conference.

Biardeau X, Aharony S; AUS Consensus Group, Campeau L, Corcos J.

Neurourol Urodyn. 2016 Apr;35(4):437-43. doi: 10.1002/nau.22999. Epub 2016 Mar 21.

PMID:
26998767
34.

Discovery and mechanistic study of a photocatalytic indoline dehydrogenation for the synthesis of elbasvir.

Yayla HG, Peng F, Mangion IK, McLaughlin M, Campeau LC, Davies IW, DiRocco DA, Knowles RR.

Chem Sci. 2016 Mar 1;7(3):2066-2073. doi: 10.1039/c5sc03350k. Epub 2015 Dec 7.

35.

Nickel-Catalyzed Asymmetric Alkene Hydrogenation of α,β-Unsaturated Esters: High-Throughput Experimentation-Enabled Reaction Discovery, Optimization, and Mechanistic Elucidation.

Shevlin M, Friedfeld MR, Sheng H, Pierson NA, Hoyt JM, Campeau LC, Chirik PJ.

J Am Chem Soc. 2016 Mar 16;138(10):3562-9. doi: 10.1021/jacs.6b00519. Epub 2016 Mar 2.

PMID:
26890979
36.

Cobalt-Catalyzed Enantioselective Hydrogenation of Minimally Functionalized Alkenes: Isotopic Labeling Provides Insight into the Origin of Stereoselectivity and Alkene Insertion Preferences.

Friedfeld MR, Shevlin M, Margulieux GW, Campeau LC, Chirik PJ.

J Am Chem Soc. 2016 Mar 16;138(10):3314-24. doi: 10.1021/jacs.5b10148. Epub 2016 Mar 1.

PMID:
26854359
37.

Enantioselective Synthesis of α-Methyl-β-cyclopropyldihydrocinnamates.

Christensen M, Nolting A, Shevlin M, Weisel M, Maligres PE, Lee J, Orr RK, Plummer CW, Tudge MT, Campeau LC, Ruck RT.

J Org Chem. 2016 Feb 5;81(3):824-30. doi: 10.1021/acs.joc.5b02296. Epub 2016 Jan 25.

PMID:
26743694
38.

Évaluation de l'efficacité d'une technique de réinnervation vésicale dans un modèle de chat paraplégique : résultats d'une étude pilote.

Ba OL, Caremel R, Aharony S, Loutochin O, Barbe M, Jacques L, Tuite G, Ruggieri M, Campeau L, Corcos J.

Prog Urol. 2015 Nov;25(13):847. doi: 10.1016/j.purol.2015.08.263. French. No abstract available.

PMID:
26544457
39.

« Rerouting » nerveux lombo-sacré pour la restauration de la vidange vésicale dans un modèle félin traumatisé médullaire : étude pilote.

Biardeau X, Biardeau X, Lam van Ba O, Caremel R, Aharony S, Lotouchin O, Barbe M, Tuite G, Jacques L, Ruggieri M, Campeau L, Corcos J.

Prog Urol. 2015 Nov;25(13):847. doi: 10.1016/j.purol.2015.08.262. French. No abstract available.

PMID:
26544456
40.

Que pouvons nous attendre du mirabégron dans la pratique urologique quotidienne ?

Biardeau X, Biardeau X, Aharony S, Campeau L, Corcos J.

Prog Urol. 2015 Nov;25(13):846-7. doi: 10.1016/j.purol.2015.08.261. French. No abstract available.

PMID:
26544455
41.

Sphincter urinaire artificiel électromécanique : résultats in vitro.

Biardeau X, Biardeau X, Hached S, Lotouchin O, Campeau L, Sawan M, Corcos J.

Prog Urol. 2015 Nov;25(13):842. doi: 10.1016/j.purol.2015.08.252. French. No abstract available.

PMID:
26544448
42.

La présence d'une bactériurie asymptomatique augmente-elle le risque de complications et/ou modifie-t-elle l'efficacité du traitement lors d'injections intra-détrusoriennes de toxine botulique A ?

Biardeau X, Biardeau X, Aharony S, Campeau L, Corcos J.

Prog Urol. 2015 Nov;25(13):736. doi: 10.1016/j.purol.2015.08.040. French. No abstract available.

PMID:
26544237
43.

Development of a Direct Photocatalytic C-H Fluorination for the Preparative Synthesis of Odanacatib.

Halperin SD, Kwon D, Holmes M, Regalado EL, Campeau LC, DiRocco DA, Britton R.

Org Lett. 2015 Nov 6;17(21):5200-3. doi: 10.1021/acs.orglett.5b02532. Epub 2015 Oct 20.

PMID:
26484983
44.

Enantioselective Synthesis of Hemiaminals via Pd-Catalyzed C-N Coupling with Chiral Bisphosphine Mono-oxides.

Li H, Belyk KM, Yin J, Chen Q, Hyde A, Ji Y, Oliver S, Tudge MT, Campeau LC, Campos KR.

J Am Chem Soc. 2015 Nov 4;137(43):13728-31. doi: 10.1021/jacs.5b05934. Epub 2015 Oct 21.

PMID:
26414910
45.

Development of a novel tricyclic class of potent and selective FIXa inhibitors.

Meng D, Andre P, Bateman TJ, Berger R, Chen YH, Desai K, Dewnani S, Ellsworth K, Feng D, Geissler WM, Guo L, Hruza A, Jian T, Li H, Metzger J, Parker DL, Reichert P, Sherer EC, Smith CJ, Sonatore LM, Tschirret-Guth R, Wu J, Xu J, Zhang T, Campeau LC, Orr R, Poirier M, McCabe-Dunn J, Araki K, Nishimura T, Sakurada I, Hirabayashi T, Wood HB.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5437-43. doi: 10.1016/j.bmcl.2015.07.078. Epub 2015 Jul 31.

PMID:
26318999
46.

Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes.

Liu P, Hu Z, DuBois BG, Moyes CR, Hunter DN, Zhu C, Kar NF, Zhu Y, Garfunkle J, Kang L, Chicchi G, Ehrhardt A, Woods A, Seo T, Woods M, van Heek M, Dingley KH, Pang J, Salituro GM, Powell J, Terebetski JL, Hornak V, Campeau LC, Lamberson J, Ujjainwalla F, Miller M, Stamford A, Wood HB, Kowalski T, Nargund RP, Edmondson SD.

ACS Med Chem Lett. 2015 Jul 10;6(8):936-41. doi: 10.1021/acsmedchemlett.5b00207. eCollection 2015 Aug 13.

47.

P2Et Phosphazene: A Mild, Functional Group Tolerant Base for Soluble, Room Temperature Pd-Catalyzed C-N, C-O, and C-C Cross-Coupling Reactions.

Buitrago Santanilla A, Christensen M, Campeau LC, Davies IW, Dreher SD.

Org Lett. 2015 Jul 2;17(13):3370-3. doi: 10.1021/acs.orglett.5b01648. Epub 2015 Jun 22.

PMID:
26099020
48.

Bone marrow mesenchymal stem cell therapy for voiding dysfunction.

Yu A, Campeau L.

Curr Urol Rep. 2015 Jul;16(7):49. doi: 10.1007/s11934-015-0516-8. Review.

PMID:
26025492
49.

Development of a novel class of potent and selective FIXa inhibitors.

Zhang T, Andre P, Bateman TJ, Chen YH, Desai K, Ellsworth K, Geissler WM, Guo L, Hruza A, Jian T, Meng D, Parker DL Jr, Qian X, Reichert P, Sherer EC, Shu M, Smith CJ, Sonatore LM, Tschirret-Guth R, Nolting AF, Orr R, Campeau LC, Araki K, Nishimura T, Sakurada I, Wood HB.

Bioorg Med Chem Lett. 2015 Nov 1;25(21):4945-4949. doi: 10.1016/j.bmcl.2015.04.057. Epub 2015 Apr 29.

PMID:
25978966
50.

Organic chemistry. Nanomole-scale high-throughput chemistry for the synthesis of complex molecules.

Buitrago Santanilla A, Regalado EL, Pereira T, Shevlin M, Bateman K, Campeau LC, Schneeweis J, Berritt S, Shi ZC, Nantermet P, Liu Y, Helmy R, Welch CJ, Vachal P, Davies IW, Cernak T, Dreher SD.

Science. 2015 Jan 2;347(6217):49-53. doi: 10.1126/science.1259203. Epub 2014 Nov 20.

Supplemental Content

Loading ...
Support Center